Tower Research Capital LLC (Trc) Moderna, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Moderna, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 60,028 shares of MRNA stock, worth $1.96 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
60,028
Previous 16,664
260.23%
Holding current value
$1.96 Million
Previous $1.11 Million
124.17%
% of portfolio
0.05%
Previous 0.03%
Shares
24 transactions
Others Institutions Holding MRNA
# of Institutions
927Shares Held
256MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.32 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.27 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$835 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$574 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$239 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...